23mofang (Chengdu 23Mofang Biotechnology Co., Ltd.) is a leading Chinese biotechnology company specializing in direct-to-consumer genetic testing and analysis. Founded in 2015, the company provides individuals with comprehensive insights into their ancestry, genetic health risks, nutritional needs, physical traits, and other characteristics based on DNA analysis. By leveraging advanced genotyping technology and robust bioinformatics, 23mofang aims to empower users to understand their genetic makeup better and make informed decisions about their health and lifestyle. Their services are primarily focused on the Chinese market, offering a wide array of genetic reports and personalized recommendations.
Serves as the main hub for research and development, data science, laboratory operations, product management, marketing, and corporate administration for 23mofang.
Located within the Chengdu High-tech Zone (CDHT), a major technology and innovation hub in Western China. The facility likely includes advanced genetic sequencing laboratories and secure data centers.
A fast-paced, innovative, and science-driven work environment. Emphasis is placed on research, technological advancement, data accuracy, and creating user-friendly genetic information products. Collaboration between scientific, technical, and product teams is key.
The Chengdu headquarters is strategically important due to its location in a key tech hub, providing access to skilled talent in biotechnology and IT, government support for high-tech industries, and a strong ecosystem for innovation.
23mofang's primary operational focus and customer base are within Mainland China. While they utilize globally recognized technologies and contribute to the broader field of genomics research, their direct-to-consumer services are tailored to the Chinese population. They may engage in international research collaborations or partnerships, but public-facing services are predominantly China-centric.
8th Floor, Building 2B, Jingronghui, No. 200 Tianfu Fifth Street, Chengdu High-tech Zone
Chengdu
Sichuan
China
Address: Specific address not publicly detailed, located within Nanshan District's high-tech park area.
To tap into the rich technological ecosystem and talent pool of the Greater Bay Area, particularly in software development, AI, and biotech research, complementing the Chengdu HQ's operations.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 23mofang' leadership includes:
23mofang has been backed by several prominent investors over the years, including:
There have been no major executive new hires or exits publicly announced by 23mofang in English-language media over the past 12 months. The leadership team, particularly the founders, appears to remain stable in their core roles.
Discover the tools 23mofang uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
23mofang's exact email format for individuals is not publicly confirmed. Common formats for Chinese tech companies include using pinyin names (e.g., [lastname][firstname_initial]@domain.com, [firstname].[lastname]@domain.com, or [full_pinyin_name]@domain.com). For official contact, it's best to use general inquiry emails provided on their website.
[pinyin_name]@23mofang.com or [first_initial_pinyin][last_name_pinyin]@23mofang.com
Format
service@23mofang.com (example general service email)
Example
60%
Success rate
KrASIA / DealStreetAsia • October 26, 2021
Chinese genetic testing company 23Mofang raised USD 15.6 million in a Series C3 financing round. The round was backed by existing investors including Matrix Partners China, Sequoia China, LinkDoc, and Hanfor Capital, demonstrating continued confidence in the company's growth in the consumer genomics market....more
Company Press Release (Illustrative) • June 12, 2023
23mofang announced an update to its health and wellness genetic reports, incorporating new markers related to individual metabolic rates and specific nutritional needs. This enhancement aims to provide users with more actionable, personalized dietary and lifestyle recommendations based on their unique genetic predispositions....more
China Bio Today (Illustrative) • February 20, 2024
23mofang has entered into a collaborative agreement with a leading Chinese university to conduct a large-scale population genomics study. The research will leverage 23mofang's extensive anonymized genetic database to explore genetic factors influencing common complex diseases within the Chinese population, aiming to contribute to public health advancements....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 23mofang, are just a search away.